Fabiflu Adverse Reactions

Clinically significant adverse reactions: Abnormal behavior (frequency unknown): Although the causal relationship is unknown, abnormal behavior (e.g. suddenly running away, wandering around) leading to a fall accident may occur in patients with influenza virus infection (See "Precautions").
Clinically significant adverse reactions (similar drugs): The following clinically significant adverse reactions have been reported with other anti-influenza virus agents. Patients should be carefully monitored, and if any abnormality is observed, the treatment should be discontinued and appropriate measures should be taken.
Shock, anaphylaxis.
Pneumonia.
Hepatitis fulminant, hepatic dysfunction, jaundice.
Toxic epidermal necrolysis (TEN), oculo-muco-cutaneous syndrome (Stevens-Johnson syndrome).
Acute kidney injury.
White blood cell count decreased, neutrophil count decreased, platelet count decreased.
Neurological and psychiatric symptoms (consciousness disturbed, deliria, hallucination, delusion, convulsion, etc.).
Colitis haemorrhagic.
Other adverse reactions*: If the following adverse reactions occur, appropriate measures should be taken according to the symptoms. (See Table 5.)

Click on icon to see table/diagram/image